前收市價 | 131.00 |
開市 | 131.00 |
買盤 | 120.35 |
賣出價 | 121.80 |
拍板 | 330.00 |
到期日 | 2024-09-20 |
今日波幅 | 131.00 - 131.00 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 4 |
Apple reports better-than-estimated earnings and expands its buyback program by $110 billion, Amgen ‘very encouraged’ by preliminary data from a trial of a weight-loss drug, and Expedia reduces its sales outlook for the year.
Controversial businessman Martin Shkreli, the former CEO of Turing Pharmaceuticals who raised the price of an essential drug from $13.50 to $750 per pill overnight, appears to have gained a new enemy. In a lengthy post on X, Shkreli shares that he "met this kid in prison" who "wanted to remake his life in crypto trading." In what Mr. Shkreli described as a "gesture of friendship", he gifted the friend 5 million tokens of a soon-to-be-released new project Martin Shkreli is working on. Don't Miss:
The crypto giant is riding high again, but the challenge, as always, is whether it can develop diverse revenue streams for the long haul.